C86.41 - Blastic NK-cell lymphoma, in remission
- Applicable to Blastic NK-cell lymphoma, in remission
- The 2025 edition of ICD10-CM C86.41 became effective on October 1, 2024.
- This is the American ICD10-CM version of C86.41 - other international versions of ICD10 C86.41 may differ.
- C86.41 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN), in remission
Billable/Specific Code
The following codes above C86.41 contain annotation back-references that may be applicable to C86.41:
- Chapter: C00-D49 - Neoplasms
- Section: C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category: C86 - Other specified types of T/NK-cell lymphoma
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com